Physician profile
Deepti Agarwal
NPI 1598901423
$2,592.00
in general payments reported to CMS, 2019-2025
24 companies · $203 in 2025
The $203 reported for 2025 was more than what 81% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $642 · 2021: $13.23 · 2022: $533 · 2023: $570 · 2024: $632 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,404.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $641.63 | 2019 | |
| Qol Medical, LLC | $390.76 | 2021-2024 | Sucraid, Sucraid |
| Abbott Laboratories | $319.85 | 2022-2024 | Eterna, Proclaim |
| Novo Nordisk INC | $242.13 | 2022-2024 | Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.75 | 2023-2025 | Xifaxan, Trulance, Plenvu |
| Pfizer INC. | $122.60 | 2023-2024 | |
| Cleerly, INC. | $105.00 | 2024-2025 | Cleerly Ischemia, Cleerly Labs |
| Takeda Pharmaceuticals U.S.A., INC. | $91.42 | 2023-2025 | Entyvio, Gattex |
| Nevro Corp. | $89.29 | 2022 | |
| Abbvie INC. | $74.71 | 2022-2025 | |
| Exact Sciences Corporation | $57.54 | 2023 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $45.43 | 2022 | |
| Lilly USA, LLC | $44.28 | 2025 | Mounjaro, Zepbound |
| Medwest Associates | $42.74 | 2022 | |
| Painteq LLC | $26.59 | 2024 | Painteq |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $24.93 | 2023 | Bridion |
| Alnylam Pharmaceuticals INC. | $23.03 | 2022 | |
| Intercept Pharmaceuticals, INC. | $22.54 | 2025 | |
| Nalu Medical, INC. | $19.69 | 2022 | |
| Averitas Pharma INC. | $18.95 | 2023 | Qutenza |
| Phadia US INC. | $18.89 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.78 | 2025 | Exparel |
| Spr Therapeutics, INC | $18.00 | 2023 | Sprint Pns System |
| Stimwave Technologies Incorporated | $7.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepti Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.